Investigational Site Number 2203
Helsinki 00100
0 studies enrolling now · 1 studies all time
What they study most
Multiple Sclerosis
Studies at this site
Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
— Completed